Page 98 - இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Mar 03, 2021 | 19:07 IST The phase 3 study enrolled 25,800 participants between 18-98 years of age, including 2,433 over the age of 60 and 4,500 with comorbidities. Representational Image  New Delhi: The Indian Council of Medical Research (ICMR) Director-General Balram Bhargava said the journey of a completely indigenous COVID-19 vaccine in less than eight months showcases the immense strength of Atmanirbhar Bharat.  “The bench-to-bedside journey of completely indigenous COVID-19 vaccine in less than eight months’ time showcases the immense strength of Atmanirbhar Bharat (self-reliant India) to fight the odds and stand tall in the global public health community, Bhargava said.  It is also a testament to India’s emergence as a global vaccine superpower,” he added.  

New delhiKrishna ellaAtmanirbhar bharatBalram bhargavaIndian council of medical researchIndian councilMedical researchDirector general balram bhargavaBharat biotechManaging directorSerum instituteCoronavirus outbreakCorona virusCovid 19Coronavirus newsIndian council for medical research